ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pegfilgrastim Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-35L10304
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and United States Pegfilgrastim Market Report Forecast 2022 2028
BUY CHAPTERS

Global Pegfilgrastim Market Research Report 2025

Code: QYRE-Auto-35L10304
Report
September 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Mylan NV
Roche

Pegfilgrastim Market Size

The global market for Pegfilgrastim was valued at US$ 59.5 million in the year 2024 and is projected to reach a revised size of US$ 82.2 million by 2031, growing at a CAGR of 4.8% during the forecast period.

Pegfilgrastim Market

Pegfilgrastim Market

Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils).
Pegfilgrastim, also known by the brand name Neulasta, is a medication used to stimulate the production of white blood cells in patients undergoing chemotherapy. The global market for pegfilgrastim is driven by several factors. One major driver for the global market is the increasing incidence and prevalence of cancer worldwide. As the number of cancer patients undergoing chemotherapy grows, the demand for medications like pegfilgrastim to manage chemotherapy-induced neutropenia (low white blood cell counts) increases. This has contributed to the market drive for pegfilgrastim. Additionally, the growing awareness and understanding of the impact of neutropenia on patient outcomes have led to the incorporation of supportive care strategies, including the use of pegfilgrastim, in cancer treatment protocols. Healthcare professionals are recognizing the importance of maintaining patients" immune systems during chemotherapy, leading to increased utilization of pegfilgrastim. Another factor driving the global market is the increasing adoption of biosimilar versions of pegfilgrastim. Biosimilars are biologic medications that are highly similar to a reference or originator biologic drug. The introduction of biosimilar pegfilgrastim options has created competition in the market, making the medication more accessible and affordable for patients and healthcare systems. Moreover, advancements in drug delivery systems have played a role in driving the market for pegfilgrastim. For instance, the development of on-body injectors that provide a longer duration of drug release has improved convenience and patient compliance. These innovations have contributed to the market drive for pegfilgrastim. Furthermore, government initiatives and policies aimed at reducing the healthcare burden of cancer treatment have also influenced the market drive for pegfilgrastim. Various healthcare systems and insurance providers have implemented measures to improve the affordability and accessibility of essential cancer treatments, including pegfilgrastim.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pegfilgrastim, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pegfilgrastim.
The Pegfilgrastim market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pegfilgrastim market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pegfilgrastim manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pegfilgrastim Market Report

Report Metric Details
Report Name Pegfilgrastim Market
Accounted market size in year US$ 59.5 million
Forecasted market size in 2031 US$ 82.2 million
CAGR 4.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Originator Biologic Drug
  • Biosimilar Versions
Segment by Application
  • Hospital
  • Drug store
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, Mylan, Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pegfilgrastim manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pegfilgrastim in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pegfilgrastim Market growing?

Ans: The Pegfilgrastim Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Pegfilgrastim Market size in 2031?

Ans: The Pegfilgrastim Market size in 2031 will be US$ 82.2 million.

Who are the main players in the Pegfilgrastim Market report?

Ans: The main players in the Pegfilgrastim Market are Amgen, Mylan, Roche

What are the Application segmentation covered in the Pegfilgrastim Market report?

Ans: The Applications covered in the Pegfilgrastim Market report are Hospital, Drug store

What are the Type segmentation covered in the Pegfilgrastim Market report?

Ans: The Types covered in the Pegfilgrastim Market report are Originator Biologic Drug, Biosimilar Versions

Recommended Reports

Cancer Therapeutics

Biologics & Biosimilars

Leukemia & Blood Disorders

1 Pegfilgrastim Market Overview
1.1 Product Definition
1.2 Pegfilgrastim by Type
1.2.1 Global Pegfilgrastim Market Value Comparison by Type (2024 VS 2031)
1.2.2 Originator Biologic Drug
1.2.3 Biosimilar Versions
1.3 Pegfilgrastim by Application
1.3.1 Global Pegfilgrastim Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Pegfilgrastim Market Size Estimates and Forecasts
1.4.1 Global Pegfilgrastim Revenue 2020-2031
1.4.2 Global Pegfilgrastim Sales 2020-2031
1.4.3 Global Pegfilgrastim Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pegfilgrastim Market Competition by Manufacturers
2.1 Global Pegfilgrastim Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pegfilgrastim Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pegfilgrastim Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pegfilgrastim, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pegfilgrastim, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pegfilgrastim, Product Type & Application
2.7 Global Key Manufacturers of Pegfilgrastim, Date of Enter into This Industry
2.8 Global Pegfilgrastim Market Competitive Situation and Trends
2.8.1 Global Pegfilgrastim Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pegfilgrastim Players Market Share by Revenue
2.8.3 Global Pegfilgrastim Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pegfilgrastim Market Scenario by Region
3.1 Global Pegfilgrastim Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pegfilgrastim Sales by Region: 2020-2031
3.2.1 Global Pegfilgrastim Sales by Region: 2020-2025
3.2.2 Global Pegfilgrastim Sales by Region: 2026-2031
3.3 Global Pegfilgrastim Revenue by Region: 2020-2031
3.3.1 Global Pegfilgrastim Revenue by Region: 2020-2025
3.3.2 Global Pegfilgrastim Revenue by Region: 2026-2031
3.4 North America Pegfilgrastim Market Facts & Figures by Country
3.4.1 North America Pegfilgrastim Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pegfilgrastim Sales by Country (2020-2031)
3.4.3 North America Pegfilgrastim Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pegfilgrastim Market Facts & Figures by Country
3.5.1 Europe Pegfilgrastim Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pegfilgrastim Sales by Country (2020-2031)
3.5.3 Europe Pegfilgrastim Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pegfilgrastim Market Facts & Figures by Region
3.6.1 Asia Pacific Pegfilgrastim Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pegfilgrastim Sales by Region (2020-2031)
3.6.3 Asia Pacific Pegfilgrastim Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pegfilgrastim Market Facts & Figures by Country
3.7.1 Latin America Pegfilgrastim Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pegfilgrastim Sales by Country (2020-2031)
3.7.3 Latin America Pegfilgrastim Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pegfilgrastim Market Facts & Figures by Country
3.8.1 Middle East and Africa Pegfilgrastim Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pegfilgrastim Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pegfilgrastim Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pegfilgrastim Sales by Type (2020-2031)
4.1.1 Global Pegfilgrastim Sales by Type (2020-2025)
4.1.2 Global Pegfilgrastim Sales by Type (2026-2031)
4.1.3 Global Pegfilgrastim Sales Market Share by Type (2020-2031)
4.2 Global Pegfilgrastim Revenue by Type (2020-2031)
4.2.1 Global Pegfilgrastim Revenue by Type (2020-2025)
4.2.2 Global Pegfilgrastim Revenue by Type (2026-2031)
4.2.3 Global Pegfilgrastim Revenue Market Share by Type (2020-2031)
4.3 Global Pegfilgrastim Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pegfilgrastim Sales by Application (2020-2031)
5.1.1 Global Pegfilgrastim Sales by Application (2020-2025)
5.1.2 Global Pegfilgrastim Sales by Application (2026-2031)
5.1.3 Global Pegfilgrastim Sales Market Share by Application (2020-2031)
5.2 Global Pegfilgrastim Revenue by Application (2020-2031)
5.2.1 Global Pegfilgrastim Revenue by Application (2020-2025)
5.2.2 Global Pegfilgrastim Revenue by Application (2026-2031)
5.2.3 Global Pegfilgrastim Revenue Market Share by Application (2020-2031)
5.3 Global Pegfilgrastim Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Pegfilgrastim Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Pegfilgrastim Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Company Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Pegfilgrastim Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan Pegfilgrastim Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Pegfilgrastim Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Pegfilgrastim Product Portfolio
6.3.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pegfilgrastim Industry Chain Analysis
7.2 Pegfilgrastim Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pegfilgrastim Production Mode & Process Analysis
7.4 Pegfilgrastim Sales and Marketing
7.4.1 Pegfilgrastim Sales Channels
7.4.2 Pegfilgrastim Distributors
7.5 Pegfilgrastim Customer Analysis
8 Pegfilgrastim Market Dynamics
8.1 Pegfilgrastim Industry Trends
8.2 Pegfilgrastim Market Drivers
8.3 Pegfilgrastim Market Challenges
8.4 Pegfilgrastim Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amgen Inc
Mylan NV
Roche
List of Tables
 Table 1. Global Pegfilgrastim Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pegfilgrastim Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pegfilgrastim Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pegfilgrastim Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pegfilgrastim Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pegfilgrastim Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pegfilgrastim Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pegfilgrastim Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pegfilgrastim, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pegfilgrastim, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pegfilgrastim, Product Type & Application
 Table 12. Global Key Manufacturers of Pegfilgrastim, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pegfilgrastim by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pegfilgrastim as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pegfilgrastim Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pegfilgrastim Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pegfilgrastim Sales Market Share by Region (2020-2025)
 Table 19. Global Pegfilgrastim Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pegfilgrastim Sales Market Share by Region (2026-2031)
 Table 21. Global Pegfilgrastim Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pegfilgrastim Revenue Market Share by Region (2020-2025)
 Table 23. Global Pegfilgrastim Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pegfilgrastim Revenue Market Share by Region (2026-2031)
 Table 25. North America Pegfilgrastim Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pegfilgrastim Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pegfilgrastim Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pegfilgrastim Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pegfilgrastim Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pegfilgrastim Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pegfilgrastim Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pegfilgrastim Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pegfilgrastim Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pegfilgrastim Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pegfilgrastim Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pegfilgrastim Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pegfilgrastim Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pegfilgrastim Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pegfilgrastim Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pegfilgrastim Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pegfilgrastim Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pegfilgrastim Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pegfilgrastim Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pegfilgrastim Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pegfilgrastim Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pegfilgrastim Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pegfilgrastim Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pegfilgrastim Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pegfilgrastim Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pegfilgrastim Sales (K Units) by Type (2020-2025)
 Table 51. Global Pegfilgrastim Sales (K Units) by Type (2026-2031)
 Table 52. Global Pegfilgrastim Sales Market Share by Type (2020-2025)
 Table 53. Global Pegfilgrastim Sales Market Share by Type (2026-2031)
 Table 54. Global Pegfilgrastim Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pegfilgrastim Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pegfilgrastim Revenue Market Share by Type (2020-2025)
 Table 57. Global Pegfilgrastim Revenue Market Share by Type (2026-2031)
 Table 58. Global Pegfilgrastim Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Pegfilgrastim Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Pegfilgrastim Sales (K Units) by Application (2020-2025)
 Table 61. Global Pegfilgrastim Sales (K Units) by Application (2026-2031)
 Table 62. Global Pegfilgrastim Sales Market Share by Application (2020-2025)
 Table 63. Global Pegfilgrastim Sales Market Share by Application (2026-2031)
 Table 64. Global Pegfilgrastim Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pegfilgrastim Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pegfilgrastim Revenue Market Share by Application (2020-2025)
 Table 67. Global Pegfilgrastim Revenue Market Share by Application (2026-2031)
 Table 68. Global Pegfilgrastim Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Pegfilgrastim Price (USD/Unit) by Application (2026-2031)
 Table 70. Amgen Company Information
 Table 71. Amgen Description and Business Overview
 Table 72. Amgen Pegfilgrastim Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Amgen Pegfilgrastim Product
 Table 74. Amgen Recent Developments/Updates
 Table 75. Mylan Company Information
 Table 76. Mylan Description and Business Overview
 Table 77. Mylan Pegfilgrastim Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Mylan Pegfilgrastim Product
 Table 79. Mylan Recent Developments/Updates
 Table 80. Roche Company Information
 Table 81. Roche Description and Business Overview
 Table 82. Roche Pegfilgrastim Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Roche Pegfilgrastim Product
 Table 84. Roche Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Pegfilgrastim Distributors List
 Table 88. Pegfilgrastim Customers List
 Table 89. Pegfilgrastim Market Trends
 Table 90. Pegfilgrastim Market Drivers
 Table 91. Pegfilgrastim Market Challenges
 Table 92. Pegfilgrastim Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pegfilgrastim
 Figure 2. Global Pegfilgrastim Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pegfilgrastim Market Share by Type: 2024 & 2031
 Figure 4. Originator Biologic Drug Product Picture
 Figure 5. Biosimilar Versions Product Picture
 Figure 6. Global Pegfilgrastim Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pegfilgrastim Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Drug store
 Figure 10. Global Pegfilgrastim Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pegfilgrastim Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Pegfilgrastim Sales (2020-2031) & (K Units)
 Figure 13. Global Pegfilgrastim Average Price (USD/Unit) & (2020-2031)
 Figure 14. Pegfilgrastim Report Years Considered
 Figure 15. Pegfilgrastim Sales Share by Manufacturers in 2024
 Figure 16. Global Pegfilgrastim Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Pegfilgrastim Players: Market Share by Revenue in Pegfilgrastim in 2024
 Figure 18. Pegfilgrastim Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Pegfilgrastim Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Pegfilgrastim Sales Market Share by Country (2020-2031)
 Figure 21. North America Pegfilgrastim Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Pegfilgrastim Sales Market Share by Country (2020-2031)
 Figure 25. Europe Pegfilgrastim Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Pegfilgrastim Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Pegfilgrastim Revenue Market Share by Region (2020-2031)
 Figure 33. China Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Pegfilgrastim Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Pegfilgrastim Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Pegfilgrastim Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Pegfilgrastim Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Pegfilgrastim Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Pegfilgrastim by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Pegfilgrastim by Type (2020-2031)
 Figure 55. Global Pegfilgrastim Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Pegfilgrastim by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Pegfilgrastim by Application (2020-2031)
 Figure 58. Global Pegfilgrastim Price (USD/Unit) by Application (2020-2031)
 Figure 59. Pegfilgrastim Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Neulasta Pegfilgrastim and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pegfilgrastim Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Granulocyte Colony Stimulating Market Insights Forecast to 2030
Global PEGylated Granulocyte Colony Stimulating Factor Market Research Report 2024
Global Human Granulocyte Colony Stimulating Factor for Injection Market Research Report 2024
Granulocyte Colony Stimulating Factor G CSF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human GM CSF for Injection Market Research Report 2024
Global Filgrastim Market Insights Forecast to 2030
Global Filgrastim Injection Market Research Report 2024
Global PEG rhG CSF Market Research Report 2025
Global Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Global Long acting Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Global Recombinant Human Granulocyte Colony Stimulating Factor Injection rhG CSF Market Research Report 2025
Global Granulocyte Macrophage Colony Stimulating Factor GM CSF Market Research Report 2024
Global Chemotherapy Induced Neutropenia CIN Drug Market Research Report 2025
Global PEGylated Proteins Market Insights Forecast to 2030
Global PEG modified Drugs Recombinant Proteins Polypeptides Market Research Report 2024
Global Granulocyte Colony stimulating Factor G CSF ELISA Kit Market Research Report 2024
Global Human Granulocyte Macrophage Colony stimulating Factor for Injection Market Research Report 2024
Global PEGylation Technology Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions